EUCTR2010-021983-14-BE进行中（未招募）不适用
A randomized placebo-controlled double blind study to treat BOS.
Z Gasthuisberg0 个研究点目标入组 30 人开始时间: 2010年9月2日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Diagnosis of fBOS
- •Signed informed consent
- •Age at least 18 years old at moment of transplantation
- •Able to take oral medication
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Retransplantation
- •Previous transplantation (solid organ)
- •Multi-organ transplantation (lung+ other solid organ)
研究者
相似试验
进行中（未招募）
不适用
A randomized placebo-controlled double blind study to prevent BOS - VIT001A study to prevent the occurence of chronic rejection after lung transplantation. Other points of investigation include lung function evolution, rate of survival, BAL cellularity, infection rate, rate of acute rejection and refluxMedDRA version: 12.1Level: LLTClassification code 10029888Term: Obliterative bronchiolitisMedDRA version: 12.1Level: LLTClassification code 10049202Term: Bronchiolitis obliteransMedDRA version: 12.1Level: LLTClassification code 10068805Term: Follicular bronchiolitisMedDRA version: 12.1Level: LLTClassification code 10019319Term: Heart-lung transplant rejectionMedDRA version: 12.1Level: LLTClassification code 10025127Term: Lung transplantMedDRA version: 12.1Level: LLTClassification code 10050433Term: Prophylaxis against lung transplant rejectionMedDRA version: 12.1Level: LLTClassification code 10050437Term: Prophylaxis against heart and lung transplant rejectionMedDRA version: 12.1Level: LLTClassification code 10051604Term: Lung transplant rejectionMedDRA version: 12.1Level: LLTClassification code 10056409Term: Heart and lung transplantMedDRA version: 12.1Level: LLTClassification code 10016547Term: FEVMedDRA version: 12.1Level: LLTClassification code 10016549Term: FEV 1 abnormalMedDRA version: 12.1Level: LLTClassification code 10016550Term: FEV 1 decreasedMedDRA version: 12.1Level: LLTClassification code 10016553Term: FEV 1 lowEUCTR2010-022027-30-BEZ Gasthuisberg
已完成
3 期
A double blind randomized placebo controlled study on the efficacy of intralymphatic immunotherapy in the treatment of grasspollen induced allergic rhinitis.Allergic rhino-conjunctivitishayfever1000170810046304NL-OMON39544HagaZiekenhuis50
撤回
2 期
A randomized double blind placebo controlled study on the effects of fenretinide Lym-X-Sorb on insulin sensitivity in obese insulin resistant subjectsobesitasimpaired glucose tolerance1001842410019654Insulin resistanceNL-OMON37344Academisch Medisch Centrum20
进行中（未招募）
1 期
SAR231893-LPS15497- Dupilumab effect on Sleep in AD patients”Atopic dermatitisEUCTR2018-004705-26-ESSanofi Aventis Groupe188
进行中（未招募）
1 期
SAR231893-LPS15497- Dupilumab effect on Sleep in AD patientsAtopic dermatitisEUCTR2018-004705-26-ITSANOFI-AVENTIS GROUPE188